| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4640559
Max Phase: Preclinical
Molecular Formula: C14H11N3O
Molecular Weight: 237.26
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Oc1cc(-c2ccccc2)nn1-c1cccnc1
Standard InChI: InChI=1S/C14H11N3O/c18-14-9-13(11-5-2-1-3-6-11)16-17(14)12-7-4-8-15-10-12/h1-10,18H
Standard InChI Key: DMIJVZIDHQAZIU-UHFFFAOYSA-N
Associated Targets(Human)
WI-38 (2654 Activities)
COQ7 Tbio 5-demethoxyubiquinone hydroxylase, mitochondrial (72 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 237.26 | Molecular Weight (Monoisotopic): 237.0902 | AlogP: 2.64 | #Rotatable Bonds: 2 |
| Polar Surface Area: 50.94 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 5.27 | CX Basic pKa: 4.76 | CX LogP: 2.36 | CX LogD: 1.16 |
| Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.75 | Np Likeness Score: -1.53 |
References
| 1. Tsuganezawa K, Sekimata K, Nakagawa Y, Utata R, Nakamura K, Ogawa N, Koyama H, Shirouzu M, Fukami T, Kita K, Tanaka A.. (2020) Identification of small molecule inhibitors of human COQ7., 28 (1): [PMID:31753803] [10.1016/j.bmc.2019.115182] |
Source
Source(1):